LATEST ALERTS
The U.S. FDA’s final deeming rule is likely to be the subject of a number of legal challenges if finalised in its current form. This could delay the application of any final regulations by several years, and could ultimately lead to a court setting the deeming rule aside – at least with regard to e-cigs.
This report examines the “next steps” for industry, the current and potential challenges, as well as the possibility of congressional relief.
